BENCHMARK PROFILE
PADRE Research Supply Company
Latest sync: Sep 18, 2026, 9:33 PM. Source coverage currently reflects PB Evidence data.
Readers who want a certificate for every product rather than a representative sample, and who will check the access code at the laboratory rather than taking the vendor’s copy on trust.
Vendor-stated: PADRE Research LLC, 13833 Wellington Trace, Ste E4 #646, Wellington, FL 33414; [email protected]. Ships from and to the United States only, via FedEx or UPS (no USPS), typically dispatched in 1–2 business days with 3–5 business day domestic delivery. Flat $12 domestic shipping, free at a $250 subtotal; card and crypto accepted. All sales are final. Purchase is limited to United States residents who attest to qualified-researcher status. Research-use-only. No PeptideBenchmark affiliate relationship. Observed September 18, 2026.
Prices and the certificate index are visible only after creating a free account, so the board figures here are a dated observation rather than a page any reader can open. Certificate coverage is complete but one batch deep — every lot is from the June 2026 series, so nothing shows how consistent later batches are. The laboratory’s ISO/IEC 17025 accreditation is scoped to cannabis testing, not peptide analysis. The business is new: the domain was registered May 17, 2026 and the Florida LLC filed June 17, 2026, there is no Trustpilot profile, and the published address is a private mailbox in a retail plaza rather than a facility. RT-3 and TRZ-2 are house labels; their certificates confirm retatrutide and tirzepatide by HPLC, and the board compares them on that basis.
A Wellington, Florida research storefront that publishes an ILS Laboratories certificate for every peptide it sells and puts its prices behind a free researcher account. Certificate coverage is complete and each lot verifies at the laboratory as well as on the vendor’s own site, but the catalog is one batch series old and the business itself is only a few months old.
PADRE Research sells eight peptides, and all eight carry a certificate of analysis from ILS Laboratories drawn from its first batch series. PeptideBenchmark checked each one twice: the certificate PADRE serves from its own storage, and the same report resolved at the laboratory’s public portal from the access code printed on it. Every lot resolves under the client name Padre Research, and the two copies are byte-identical. Reported purity runs 99.13% to 99.91%, and each report covers HPLC purity and identity, a fentanyl screen, heavy metals by ICP-MS, sterility by PCR, and a quantitative endotoxin result. Prices and the certificate index require a free account; the certificate documents themselves are served publicly.
Every peptide in the catalog has a certificate, and every certificate is independently checkable: the printed access code resolves at ILS Laboratories’ own portal under the client name Padre Research, returning the same report PADRE publishes. Coverage is complete for the current catalog but shallow in time — all eight lots come from the vendor’s first batch series, tested in July 2026, so there is no batch history to compare against yet. One qualification on the accreditation PADRE cites: ILS holds a current ISO/IEC 17025:2017 accreditation from PJLA, but its scope covers cannabis and hemp testing rather than peptide analysis, so it should not be read as extending to the panels on these certificates. That applies to every vendor using this laboratory, not only PADRE.
This vendor is one of 119 names currently included in our manual curated research-vendor layer.
This is the strongest public transparency pattern on the site. The key signal is that readers can leave the vendor domain and inspect reports or verification pages on an outside provider domain without needing to log in.
- Treat the outside provider route as the strongest part of the evidence, not the vendor marketing copy around it.
- Look for repeated product-level behavior across the catalog, not just one showcase example.
- Do not overread it as proof that every current lot is covered or current unless the linked report trail itself supports that.
This vendor makes the most sense when you compare it to other vendors using a similar transparency model, rather than to every vendor on the board at once.
PB Curated Assessment is a PeptideBenchmark-authored rubric built from the trust and transparency review layer. It is separate from the source-derived benchmark score.
PADRE Research Supply Company is currently one of the strongest curated cases on the site because readers can inspect a repeatable public evidence trail without logging in.
Readers can leave the vendor marketing layer and inspect verification publicly.
This is the strongest public pattern because the verification step routes into an outside provider layer.
Current review touched 8 products and 8 document/link destinations.
1 named lab signal(s) and 1 certification category signal(s) are currently visible in the reviewed evidence.
Score 6.8 from pb evidence score.
PB Curated Assessment: Strong. This is our own trust/transparency rubric and is kept separate from the PB score.
Under the formula retired on Aug 28, 2026 this vendor scores 6.91 — the live evidence-first score is 8.08 (+1.17). What changed and why: scoring methodology.
Holding a certificate for this vendor that is not here?Send it to the archive →
Same third-party review signals shown on the vendor board. Click Trustpilot or Pep Review Pro to open the source profile.
PB score is the number you should read first on this page. It starts with trust evidence, pricing coverage, and third-party review signals from Finnrick, Peptide Critic, Trustpilot, and Pep Review Pro when available. Reviewed transparency evidence contributes a bounded amount — shown as a trust lift for source-benchmarked vendors, and folded into the base score for PB-evidence vendors.
This vendor’s score is evidence-first: verifiable testing evidence forms the backbone, and outside review sources are a bounded adjustment that can warn far more than it can boost. The terms below sum to the displayed score (small rounding aside). Full formula on the scoring methodology page.
WHAT THIS PAGE IS
- Board-ranked vendor profile with source-linked benchmark inputs
- No Finnrick score currently linked
- No Peptide Critic score currently linked
- No Trustpilot profile currently linked
- No Pep Review Pro profile currently linked
CURRENT LIMITS
- Not an original lab test or editorial review
- Source scales and methodologies differ across sites
- Depends on source site freshness and formatting
These are representative public examples from the vendor testing review queue. They show how product pages in the catalog expose public report or verification paths, but they should still be read as examples rather than proof for every current lot.
In other words: the relationship registry above captures the vendor-to-provider link itself, while the examples below show what that link looks like across real product pages.
METHODOLOGY
How to read this benchmark
This profile summarizes public benchmark data synced from Finnrick and, when available, Peptide Critic. Finnrick contributes a 10-point average from its vendor table, while Peptide Critic contributes a 5-star rating that we normalize to a 10-point scale before ranking consensus entries.
A high score can be directionally useful, but it is not a substitute for current COAs, identity testing, chain-of-custody details, or your own due diligence. We are intentionally separating source aggregation from first-party editorial claims.
Scores combine PB trust evidence with external signals from Finnrick, Peptide Critic, Trustpilot, and Pep Review Pro when available.